Literature DB >> 23119906

Nodal metastases from laryngeal carcinoma and their correlation with certain characteristics of the primary tumor.

Kamaljit Kaur1, Nishi Sonkhya, A S Bapna.   

Abstract

5O cases of carcinoma larynx were included in a prospective study to detect the incidence and pattern of nodal metastases (both clinical and occult) and to study the influence of certain characteristics of the primary tumor on the incidence of nodal metastases. In our study 66% (33 cases) of the lesions were transglottic as compared to 24% (12 cases) supraglottic and 10% (5 cases) glottic lesions. The most common age group affected in our study was 51-60 years comprising 50% of the cases. The most common symptoms were hoarseness, breathlessness and difficulty in swallowing. The incidence of clinically positive neck at the time of presentation was 42% while the incidence of occult nodal metastases was found to be 27.6%. The most common levels of lymph nodes involved in our study were levels II and III (87.5% cases). Multiple level lymph node involvement was seen in 71.4% of the eases at the time of presentation. A high incidence of cervical nodal metastases was associated with the following characteristics of the primary lesion-extralaryngeal spread, infiltrating or endophytic peripheral growth pattern, poor cellular differentiation and advanced T stage. In view of the high incidence of occult nodal metastases, use of selective lateral neck dissection is advocated in patients with a clinically negative neck at the-time of presentation (early glottic carcinomas being excluded).

Entities:  

Keywords:  Carcinoma larynx; nodal metastases

Year:  2002        PMID: 23119906      PMCID: PMC3450474          DOI: 10.1007/BF02993738

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  23 in total

1.  Supraglottic carcinomas: The early cases.

Authors:  Y Cachin
Journal:  Laryngoscope       Date:  1975-10       Impact factor: 3.325

2.  A statistical study of 620 laryngeal carcinomas of the glottic region personally operated upon more than five years ago.

Authors:  J Leroux-Robert
Journal:  Laryngoscope       Date:  1975-09       Impact factor: 3.325

3.  Correlation between prognosis and degree of lymph node involvement in carcinoma of the oral cavity.

Authors:  I K Kalnins; A G Leonard; K Sako; M S Razack; D P Shedd
Journal:  Am J Surg       Date:  1977-10       Impact factor: 2.565

4.  Modes of invasion of cancer of the larynx. A statistical, histological, and radioclinical analysis of 120 cases.

Authors:  C Micheau; B Luboinski; H Sancho; Y Cachin
Journal:  Cancer       Date:  1976-07       Impact factor: 6.860

5.  Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts.

Authors:  R Lindberg
Journal:  Cancer       Date:  1972-06       Impact factor: 6.860

6.  Patterns of nodal metastasis and surgical management of the neck in supraglottic laryngeal carcinoma.

Authors:  W L Hicks; D R Kollmorgen; M A Kuriakose; J Orner; V Y Bakamjian; J Winston; T R Loree
Journal:  Otolaryngol Head Neck Surg       Date:  1999-07       Impact factor: 3.497

7.  Revision of classification of laryngeal cancer, is it long overdue? (Proposals for an improved TN-classification).

Authors:  O Kleinsasser
Journal:  J Laryngol Otol       Date:  1992-03       Impact factor: 1.469

8.  The level of cervical lymph node metastases: their prognostic relevance and relationship with head and neck squamous carcinoma primary sites.

Authors:  A S Jones; N J Roland; J K Field; D E Phillips
Journal:  Clin Otolaryngol Allied Sci       Date:  1994-02

9.  Selective jugular node dissection in patients with squamous carcinoma of the larynx or pharynx.

Authors:  R H Spiro; O Gallo; J P Shah
Journal:  Am J Surg       Date:  1993-10       Impact factor: 2.565

10.  [The relationship between histologic grading of malignancy and regional lymph node metastasis in squamous cell carcinoma of larynx].

Authors:  Y Wang; J Tian; Z Ren
Journal:  Lin Chuang Er Bi Yan Hou Ke Za Zhi       Date:  1997-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.